Skip to main content
PMC home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(3):211–214. doi: 10.1155/S1064744997000343

Cefuroxime Axetil (Ceftin®): A Brief Review

Rachel Deanne Leder 1, Deborah Stier Carson 2,✉
PMCID: PMC2364541  PMID: 18476138

Full Text

The Full Text of this article is available as a PDF (352.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baddour L. M., Gibbs R. S., Mertz G., Cocchetto D. M., Noble R. C. Clinical comparison of single-oral-dose cefuroxime axetil and amoxicillin with probenecid for uncomplicated gonococcal infections in women. Antimicrob Agents Chemother. 1989 Jun;33(6):801–804. doi: 10.1128/aac.33.6.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradley J. S., Kaplan S. L., Klugman K. P., Leggiadro R. J. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J. 1995 Dec;14(12):1037–1041. [PubMed] [Google Scholar]
  3. Cooper J., Raeburn A., Brumfitt W., Hamilton-Miller J. M. Comparative efficacy and tolerability of cephradine and cefuroxime axetil in the treatment of acute dysuria and/or frequency in general practice. Br J Clin Pract. 1992 Spring;46(1):24–27. [PubMed] [Google Scholar]
  4. Das R. P., Jones K., Robinson A. J., Timmins D. J. Cefuroxime axetil to treat gonorrhea. Genitourin Med. 1988 Dec;64(6):394–394. doi: 10.1136/sti.64.6.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Finn A., Straughn A., Meyer M., Chubb J. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos. 1987 Nov-Dec;8(6):519–526. doi: 10.1002/bdd.2510080604. [DOI] [PubMed] [Google Scholar]
  6. Fong I. W., Linton W., Simbul M., Hinton N. A. Comparative clinical efficacy of single oral doses of cefuroxime axetil and amoxicillin in uncomplicated gonococcal infections. Antimicrob Agents Chemother. 1986 Aug;30(2):321–322. doi: 10.1128/aac.30.2.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Foord R. D. Cefuroxime: human pharmacokinetics.. Antimicrob Agents Chemother. 1976 May;9(5):741–747. doi: 10.1128/aac.9.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ginsburg C. M., McCracken G. H., Jr, Petruska M., Olson K. Pharmacokinetics and bactericidal activity of cefuroxime axetil. Antimicrob Agents Chemother. 1985 Oct;28(4):504–507. doi: 10.1128/aac.28.4.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gottlieb A., Mills J. Cefuroxime axetil for treatment of uncomplicated gonorrhea. Antimicrob Agents Chemother. 1986 Aug;30(2):333–334. doi: 10.1128/aac.30.2.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harding S. M., Williams P. E., Ayrton J. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother. 1984 Jan;25(1):78–82. doi: 10.1128/aac.25.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iravani A., Richard G. A. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. Antimicrob Agents Chemother. 1989 Aug;33(8):1212–1216. doi: 10.1128/aac.33.8.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kees F., Lukassek U., Naber K. G., Grobecker H. Comparative investigations on the bioavailability of cefuroxime axetil. Arzneimittelforschung. 1991 Aug;41(8):843–846. [PubMed] [Google Scholar]
  13. Konishi K., Suzuki H., Hayashi M., Saruta T. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function. J Antimicrob Chemother. 1993 Mar;31(3):413–420. doi: 10.1093/jac/31.3.413. [DOI] [PubMed] [Google Scholar]
  14. Naber K. G., Koch E. M. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women. Infection. 1993 Jan-Feb;21(1):34–39. doi: 10.1007/BF01739308. [DOI] [PubMed] [Google Scholar]
  15. Neu H. C., Fu K. P. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob Agents Chemother. 1978 Apr;13(4):657–664. doi: 10.1128/aac.13.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Perry C. M., Brogden R. N. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1996 Jul;52(1):125–158. doi: 10.2165/00003495-199652010-00009. [DOI] [PubMed] [Google Scholar]
  17. Reichman R. C., Nolte F. S., Wolinsky S. M., Greisberger C. A., Trupei M. A., Nitzkin J. Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: a controlled trial. Sex Transm Dis. 1985 Oct-Dec;12(4):184–187. doi: 10.1097/00007435-198510000-00003. [DOI] [PubMed] [Google Scholar]
  18. Schift R., van Ulsen J., Ansink-Schipper M. C., van Joost T., Michel M. F., Woudstra R. K., Stolz E. Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin). Genitourin Med. 1986 Oct;62(5):313–317. doi: 10.1136/sti.62.5.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sirot J., Chanal C., Petit A., Sirot D., Labia R., Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis. 1988 Jul-Aug;10(4):850–859. doi: 10.1093/clinids/10.4.850. [DOI] [PubMed] [Google Scholar]
  20. Wanas T. M., Williams P. E. Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea. Genitourin Med. 1986 Aug;62(4):221–223. doi: 10.1136/sti.62.4.221. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES